Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109351) titled 'Skin Sensitization Activity of BTM Multiple Skin Care Products' on April 24.
Study Type: Interventional
Study Design:
Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label
Primary Sponsor: BTM Ventures Pvt
Intervention:
Intervention1: Finn Chamber: Each Patch contain 0.04ml/(40 microgram) of test sample,1.Vitamin C face Serum
2.Niacinamide face Serum
3.Vitamin C facewash
4.Niacinamide Face Wash, Administration: Topical Frequency: every second day- as per BIS 4011 Duration: 41 days
Control Intervention1:...